Evelo Biosciences Financials
EVLODelisted Stock | USD 0.09 0.17 66.00% |
Evelo |
Understanding current and past Evelo Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Evelo Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Evelo Biosciences' assets may result in an increase in income on the income statement.
The data published in Evelo Biosciences' official financial statements usually reflect Evelo Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Evelo Biosciences. For example, before you start analyzing numbers published by Evelo accountants, it's critical to develop an understanding of what Evelo Biosciences' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Evelo Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evelo Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Evelo Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evelo Biosciences. Please utilize our Beneish M Score to check the likelihood of Evelo Biosciences' management manipulating its earnings.
Evelo Biosciences Stock Summary
Evelo Biosciences competes with Aileron Therapeutics, ABVC Biopharma, Surrozen, Processa Pharmaceuticals, and Neximmune. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Evelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.Specialization | Healthcare, Biotechnology |
Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US2997341035 |
CUSIP | 299734103 299734202 |
Location | Massachusetts; U.S.A |
Business Address | 620 Memorial Drive, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | NYSE Composite |
Website | www.evelobio.com |
Phone | 617 577 0300 |
Currency | USD - US Dollar |
You should never invest in Evelo Biosciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Evelo Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Evelo Biosciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Evelo Biosciences Key Financial Ratios
Generally speaking, Evelo Biosciences' financial ratios allow both analysts and investors to convert raw data from Evelo Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Evelo Biosciences over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Evelo Biosciences reports annually and quarterly.Return On Equity | -62.33 | ||||
Return On Asset | -0.83 | ||||
Target Price | 10.0 |
Evelo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evelo Biosciences's current stock value. Our valuation model uses many indicators to compare Evelo Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evelo Biosciences competition to find correlations between indicators driving Evelo Biosciences's intrinsic value. More Info.Evelo Biosciences is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evelo Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evelo Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evelo Biosciences' earnings, one of the primary drivers of an investment's value.Evelo Biosciences Market Pulse
Quote | 0.085 |
Change(%) | 66.00 |
Change | 0.17 |
Open | 0.25 |
Low | 0.071 |
High | 0.25 |
Volume | 0 |
Exchange | PINK |
About Evelo Biosciences Financials
What exactly are Evelo Biosciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Evelo Biosciences' income statement, its balance sheet, and the statement of cash flows. Potential Evelo Biosciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Evelo Biosciences investors may use each financial statement separately, they are all related. The changes in Evelo Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evelo Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Evelo Biosciences Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Evelo Biosciences is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Evelo has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Evelo Biosciences' financials are consistent with your investment objective using the following steps:- Review Evelo Biosciences' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Evelo Biosciences' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Evelo Biosciences' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Evelo Biosciences' stock is overvalued or undervalued.
Evelo Biosciences May 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Evelo Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evelo Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evelo Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Evelo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evelo Biosciences's daily price indicators and compare them against related drivers.
Information Ratio | (0.26) | |||
Maximum Drawdown | 96.88 | |||
Value At Risk | (21.31) | |||
Potential Upside | 14.0 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |